AMR Gene Summary Report
=======================
Generated: 2024-01-15
Sample: o_unicycler/assembly.fasta
Database: NCBI AMRFinderPlus

Total AMR genes found: 16

BETA-LACTAM RESISTANCE:
1. blaNDM-7 (Carbapenemase)
   Location: contig_32:2466-3278
   Coverage: 100.00% | Identity: 100.00%
   Resistance: CARBAPENEM (meropenem, imipenem, ertapenem)
   Clinical significance: CRITICAL - Carbapenem-resistant Enterobacteriaceae (CRE)

2. blaCTX-M-15 (ESBL)
   Location: contig_30:7341-8216
   Coverage: 100.00% | Identity: 100.00%
   Resistance: Extended-spectrum cephalosporins (3rd/4th gen)
   Clinical significance: HIGH

3. blaTEM-1 (Penicillinase)
   Location: contig_30:3659-4519
   Coverage: 100.00% | Identity: 100.00%
   Resistance: Ampicillin, penicillins

4. blaSHV-106 (ESBL)
   Location: contig_7:245723-246583
   Coverage: 100.00% | Identity: 99.88%
   Resistance: Extended-spectrum cephalosporins

5. blaOXA-1 (Oxacillinase)
   Location: contig_44:777-1607
   Coverage: 100.00% | Identity: 100.00%
   Resistance: Cephalosporins

AMINOGLYCOSIDE RESISTANCE:
6. aac(6')-Ib-D181Y | aac(3)-IIe | aph(3'')-Ib | aph(6)-Id
   Resistance: Amikacin, kanamycin, tobramycin, gentamicin, streptomycin

QUINOLONE RESISTANCE:
7. qnrB1 | oqxA5 | oqxB19
   Resistance: Fluoroquinolones (ciprofloxacin, levofloxacin)

OTHER RESISTANCE:
8. sul2 - Sulfonamide resistance
9. dfrA14 - Trimethoprim resistance
10. fosA6 - Fosfomycin resistance
11. ble-MBL - Bleomycin resistance

CLINICAL INTERPRETATION:
This isolate is a MULTI-DRUG RESISTANT (MDR) organism with carbapenem resistance.
- AVOID: Carbapenems, cephalosporins, penicillins, aminoglycosides, fluoroquinolones, sulfonamides, trimethoprim
- CONSIDER: Colistin, tigecycline (susceptibility testing required)
- Report to infection control for CRE surveillance